PTSD – Society of Cannabis Clinicians https://www.cannabisclinicians.org Educating Healthcare Professionals about the Medical Use of Cannabis Sun, 15 Oct 2023 02:34:43 +0000 en-US hourly 1 https://wordpress.org/?v=6.2.3 https://www.cannabisclinicians.org/wp-content/uploads/2020/07/cropped-scc-flavicon-32x32.png PTSD – Society of Cannabis Clinicians https://www.cannabisclinicians.org 32 32 Anxiety severity and prescription medication utilization in first-time medical marijuana users https://www.cannabisclinicians.org/2023/10/14/anxiety-severity-and-prescription-medication-utilization-in-first-time-medical-marijuana-users/ Sun, 15 Oct 2023 02:34:43 +0000 https://www.cannabisclinicians.org/?p=29435 Anxiety and post-traumatic stress disorder (PTSD) are qualifying psychiatric conditions for medical marijuana (MM) treatment in Pennsylvania. This study examined baseline prevalence and changes in prescription anxiety medication use three months following MM treatment initiation among individuals with these qualifying conditions. The study sample was comprised of 108 adults with anxiety or PTSD as a referring condition; they were enrolled in a longitudinal study evaluating biopsychosocial outcomes in new MM patients. Consenting participants completed an assessment battery at baseline and Month 3 (n = 94, 87 % follow-up rate) that included a measure of anxiety severity and questions about current anxiety medication prescription and desired (baseline) and actual (Month 3) reductions in medication use.

The post Anxiety severity and prescription medication utilization in first-time medical marijuana users appeared first on Society of Cannabis Clinicians.

]]> The Effectiveness and Adverse Events of Cannabidiol and Tetrahydrocannabinol Used in the Treatment of Anxiety Disorders in a PTSD Subpopulation: An Interim Analysis of an Observational Study https://www.cannabisclinicians.org/2023/07/22/the-effectiveness-and-adverse-events-of-cannabidiol-and-tetrahydrocannabinol-used-in-the-treatment-of-anxiety-disorders-in-a-ptsd-subpopulation-an-interim-analysis-of-an-observational-study/ Sat, 22 Jul 2023 15:31:38 +0000 https://www.cannabisclinicians.org/?p=28949 Anxiety is a condition for which current treatments are often limited by adverse events (AEs). Components of medicinal cannabis, cannabidiol (CBD) and tetrahydrocannabinol (THC), have been proposed as potential treatments for anxiety disorders, specifically posttraumatic stress disorder (PTSD). To evaluate quality-of-life outcomes after treatment with various cannabis formulations to determine the effectiveness and associated AEs.

The post The Effectiveness and Adverse Events of Cannabidiol and Tetrahydrocannabinol Used in the Treatment of Anxiety Disorders in a PTSD Subpopulation: An Interim Analysis of an Observational Study appeared first on Society of Cannabis Clinicians.

]]> The therapeutic role of Cannabidiol in mental health: a systematic review https://www.cannabisclinicians.org/2022/03/14/the-therapeutic-role-of-cannabidiol-in-mental-health-a-systematic-review/ Mon, 14 Mar 2022 22:50:22 +0000 https://www.cannabisclinicians.org/?p=26278 The therapeutic application of cannabidiol (CBD) is gaining interest due to expanding evidence for its use.
Objective: To summarize the clinical outcomes, study designs and limitations for the use of CBD and nabiximols (whole plant extract from Cannabis sativa L. that has been purified into 1:1 ratio of CBD and delta-9- tetrahydrocannabinol) in the treatment of psychiatric disorders.

The post The therapeutic role of Cannabidiol in mental health: a systematic review appeared first on Society of Cannabis Clinicians.

]]> Cannabis in the management of PTSD: a systematic review https://www.cannabisclinicians.org/2021/07/08/cannabis-in-the-management-of-ptsd-a-systematic-review/ Thu, 08 Jul 2021 20:14:42 +0000 https://www.cannabisclinicians.org/?p=23647 Existing reviews exploring cannabis effectiveness have numerous limitations including narrow search strategies. We systematically explored cannabis effects on PTSD symptoms, quality of life (QOL), and return to work (RTW). We also investigated harm outcomes such as adverse effects and dropouts due to adverse effects, inefficacy, and all-cause dropout rates.

The post Cannabis in the management of PTSD: a systematic review appeared first on Society of Cannabis Clinicians.

]]> Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes. https://www.cannabisclinicians.org/2016/07/01/clinical-endocannabinoid-deficiency-reconsidered-current-research-supports-the-theory-in-migraine-fibromyalgia-irritable-bowel-and-other-treatment-resistant-syndromes/ Fri, 01 Jul 2016 17:03:54 +0000 https://www.cannabisclinicians.org/?p=15015 Authors: Ethan B. Russo
Cannabis and Cannabinoid Research, 1 July 2016
---
Medicine continues to struggle in its approaches to numerous common subjective pain syndromes that lack objective signs and remain treatment resistant. Foremost among these are migraine, fibromyalgia, and irritable bowel syndrome, disorders that may overlap in their affected p...

The post Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes. appeared first on Society of Cannabis Clinicians.

]]> Use and effects of cannabinoids in military veterans with posttraumatic stress disorder. https://www.cannabisclinicians.org/2015/08/01/use-and-effects-of-cannabinoids-in-military-veterans-with-ptsd/ Sat, 01 Aug 2015 17:56:54 +0000 http://cannabisclinicians.org/?p=11141 Authors: Kevin Betthauser, Jeffrey Pilz, Laura E. Vollmer
American Journal of Health-System Pharmacy, 1 August 2015
---
PURPOSE: Published evidence regarding the use of cannabis and cannabis derivatives by military veterans with posttraumatic stress disorder (PTSD) is reviewed. SUMMARY: When inhaled or delivered orally or transdermally, cannabinoids (the psychoactive components of unrefined mar...

The post Use and effects of cannabinoids in military veterans with posttraumatic stress disorder. appeared first on Society of Cannabis Clinicians.

]]> PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program. https://www.cannabisclinicians.org/2014/02/01/ptsd-patients-evaluated-for-new-mexico-medical-cannabis-program/ Sat, 01 Feb 2014 17:35:20 +0000 http://cannabisclinicians.org/?p=10902 Authors: George R. Greer, Charles S. Grob, Adam L. Halberstadt
Journal of Psychoactive Drugs, January-March 2014
---
BACKGROUND: New Mexico was the first state to list post-traumatic stress disorder (PTSD) as a condition for the use of medical cannabis. There are no published studies, other than case reports, of the effects of cannabis on PTSD symptoms. The purpose of the study was to report...

The post PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program. appeared first on Society of Cannabis Clinicians.

]]> Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. https://www.cannabisclinicians.org/2013/09/01/elevated-brain-cannabinoid-cb1-receptor-availability-in-post-traumatic-stress-disorder-a-positron-emission-tomography-study/ Sun, 01 Sep 2013 19:20:16 +0000 https://www.cannabisclinicians.org/?p=15483 Authors: A Neumeister, M D Normandin, R H Pietrzak, D Piomelli, M Q Zheng, A Gujarro-Anton, et al
Molecular Psychiatry, September 2013
---
Endocannabinoids and their attending cannabinoid type 1 (CB1) receptor have been implicated in animal models of post-traumatic stress disorder (PTSD). However, their specific role has not been studied in people with PTSD. Herein, we present an in vivo imaging study using posit...

The post Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. appeared first on Society of Cannabis Clinicians.

]]> The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD). https://www.cannabisclinicians.org/2013/08/09/the-endocannabinoid-system-as-a-possible-target-to-treat-both-the-cognitive-and-emotional-features-of-post-traumatic-stress-disorder-ptsd/ Fri, 09 Aug 2013 14:26:13 +0000 https://www.cannabisclinicians.org/?p=15489 Post-traumatic stress disorder (PTSD) is a psychiatric disorder of significant prevalence and morbidity, whose pathogenesis relies on paradoxical changes of emotional memory processing. An ideal treatment would be a drug able to block the pathological over-consolidation and continuous retrieval of the traumatic event, while enhancing its extinction and reducing the anxiety symptoms.

The post The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD). appeared first on Society of Cannabis Clinicians.

]]> Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence. https://www.cannabisclinicians.org/2012/07/30/mitigation-of-post-traumatic-stress-symptoms-by-cannabis-resin-a-review-of-the-clinical-and-neurobiological-evidence/ Mon, 30 Jul 2012 14:41:13 +0000 https://www.cannabisclinicians.org/?p=15491 Authors: Torsten Passie, Hinderk M. Emrich, Matthias Karst, Simon D. Brandt, John H. Halpern
Drug Testing and Analysis, July-August 2012
---
It is known from clinical studies that some patients attempt to cope with the symptoms of post-traumatic stress disorder (PTSD) by using recreational drugs. This review presents a case report of a 19-year-old male patient with a spectrum of severe PTSD symptoms, such as intens...

The post Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence. appeared first on Society of Cannabis Clinicians.

]]>